EUR/USD remains vulnerable below key resistance at 1.1590, with a bearish setup targeting 1.1475 amid cautious Fed commentary and mixed eurozone data.
Excellent profit margins, understated future earnings potential, and winning the bidding war for Metsera have injected bullishness. Should you buy Pfizer following the Metsera deal?